Literature DB >> 27114511

Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires.

Brandon J DeKosky1, Oana I Lungu2, Daechan Park2, Erik L Johnson1, Wissam Charab1, Constantine Chrysostomou1, Daisuke Kuroda3, Andrew D Ellington4, Gregory C Ippolito5, Jeffrey J Gray3, George Georgiou6.   

Abstract

Elucidating how antigen exposure and selection shape the human antibody repertoire is fundamental to our understanding of B-cell immunity. We sequenced the paired heavy- and light-chain variable regions (VH and VL, respectively) from large populations of single B cells combined with computational modeling of antibody structures to evaluate sequence and structural features of human antibody repertoires at unprecedented depth. Analysis of a dataset comprising 55,000 antibody clusters from CD19(+)CD20(+)CD27(-) IgM-naive B cells, >120,000 antibody clusters from CD19(+)CD20(+)CD27(+) antigen-experienced B cells, and >2,000 RosettaAntibody-predicted structural models across three healthy donors led to a number of key findings: (i) VH and VL gene sequences pair in a combinatorial fashion without detectable pairing restrictions at the population level; (ii) certain VH:VL gene pairs were significantly enriched or depleted in the antigen-experienced repertoire relative to the naive repertoire; (iii) antigen selection increased antibody paratope net charge and solvent-accessible surface area; and (iv) public heavy-chain third complementarity-determining region (CDR-H3) antibodies in the antigen-experienced repertoire showed signs of convergent paired light-chain genetic signatures, including shared light-chain third complementarity-determining region (CDR-L3) amino acid sequences and/or Vκ,λ-Jκ,λ genes. The data reported here address several longstanding questions regarding antibody repertoire selection and development and provide a benchmark for future repertoire-scale analyses of antibody responses to vaccination and disease.

Entities:  

Keywords:  B cell; antibody; computational modeling; high-throughput sequencing; immunology

Mesh:

Substances:

Year:  2016        PMID: 27114511      PMCID: PMC4868480          DOI: 10.1073/pnas.1525510113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

1.  High-throughput antibody sequencing reveals genetic evidence of global regulation of the naïve and memory repertoires that extends across individuals.

Authors:  B S Briney; J R Willis; B A McKinney; J E Crowe
Journal:  Genes Immun       Date:  2012-05-24       Impact factor: 2.676

Review 2.  Antibody structure and the evolution of immunoglobulin V gene segments.

Authors:  P M Kirkham; H W Schroeder
Journal:  Semin Immunol       Date:  1994-12       Impact factor: 11.130

Review 3.  Sequencing the functional antibody repertoire--diagnostic and therapeutic discovery.

Authors:  William H Robinson
Journal:  Nat Rev Rheumatol       Date:  2014-12-23       Impact factor: 20.543

4.  Divergent human populations show extensive shared IGK rearrangements in peripheral blood B cells.

Authors:  Katherine Jean Louise Jackson; Yan Wang; Bruno A Gaeta; William Pomat; Peter Siba; Janet Rimmer; William A Sewell; Andrew M Collins
Journal:  Immunogenetics       Date:  2011-07-26       Impact factor: 2.846

5.  Convergent antibody signatures in human dengue.

Authors:  Poornima Parameswaran; Yi Liu; Krishna M Roskin; Katherine K L Jackson; Vaishali P Dixit; Ji-Yeun Lee; Karen L Artiles; Simona Zompi; Maria José Vargas; Birgitte B Simen; Bozena Hanczaruk; Kim R McGowan; Muhammad A Tariq; Nader Pourmand; Daphne Koller; Angel Balmaseda; Scott D Boyd; Eva Harris; Andrew Z Fire
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

6.  Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody.

Authors:  Aaron G Schmidt; Huafeng Xu; Amir R Khan; Timothy O'Donnell; Surender Khurana; Lisa R King; Jody Manischewitz; Hana Golding; Pirada Suphaphiphat; Andrea Carfi; Ethan C Settembre; Philip R Dormitzer; Thomas B Kepler; Ruijun Zhang; M Anthony Moody; Barton F Haynes; Hua-Xin Liao; David E Shaw; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-21       Impact factor: 11.205

7.  λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies.

Authors:  Mohammad M Sajadi; Maham Farshidpour; Eric P Brown; Xin Ouyang; Michael S Seaman; Marzena Pazgier; Margaret E Ackerman; Harriet Robinson; Georgia Tomaras; Matthew S Parsons; Manhattan Charurat; Anthony L DeVico; Robert R Redfield; George K Lewis
Journal:  J Infect Dis       Date:  2015-09-07       Impact factor: 5.226

8.  Redistribution of flexibility in stabilizing antibody fragment mutants follows Le Châtelier's principle.

Authors:  Tong Li; Malgorzata B Tracka; Shahid Uddin; Jose Casas-Finet; Donald J Jacobs; Dennis R Livesay
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

9.  The relationship between CD27 negative and positive B cell populations in human peripheral blood.

Authors:  Yu-Chang Bryan Wu; David Kipling; Deborah K Dunn-Walters
Journal:  Front Immunol       Date:  2011-12-26       Impact factor: 7.561

10.  Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences.

Authors:  Jacob D Galson; Johannes Trück; Anna Fowler; Elizabeth A Clutterbuck; Márton Münz; Vincenzo Cerundolo; Claudia Reinhard; Robbert van der Most; Andrew J Pollard; Gerton Lunter; Dominic F Kelly
Journal:  EBioMedicine       Date:  2015-11-24       Impact factor: 8.143

View more
  81 in total

1.  Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.

Authors:  Kathryn E Tiller; Lijuan Li; Sandeep Kumar; Mark C Julian; Shekhar Garde; Peter M Tessier
Journal:  J Biol Chem       Date:  2017-08-04       Impact factor: 5.157

Review 2.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

Review 3.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

4.  Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.

Authors:  Bharat Madan; Baoshan Zhang; Kai Xu; Cara W Chao; Sijy O'Dell; Jacy R Wolfe; Gwo-Yu Chuang; Ahmed S Fahad; Hui Geng; Rui Kong; Mark K Louder; Thuy Duong Nguyen; Reda Rawi; Arne Schön; Zizhang Sheng; Rajani Nimrania; Yiran Wang; Tongqing Zhou; Bob C Lin; Nicole A Doria-Rose; Lawrence Shapiro; Peter D Kwong; Brandon J DeKosky
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

5.  VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage.

Authors:  Chen-Hsiang Shen; Brandon J DeKosky; Yicheng Guo; Kai Xu; Ying Gu; Divya Kilam; Sung Hee Ko; Rui Kong; Kevin Liu; Mark K Louder; Li Ou; Baoshan Zhang; Cara W Chao; Martin M Corcoran; Eric Feng; Jesse Huang; Erica Normandin; Sijy O'Dell; Amy Ransier; Reda Rawi; Mallika Sastry; Stephen D Schmidt; Shuishu Wang; Yiran Wang; Gwo-Yu Chuang; Nicole A Doria-Rose; Bob Lin; Tongqing Zhou; Eli A Boritz; Mark Connors; Daniel C Douek; Gunilla B Karlsson Hedestam; Zizhang Sheng; Lawrence Shapiro; John R Mascola; Peter D Kwong
Journal:  Cell Host Microbe       Date:  2020-03-03       Impact factor: 21.023

6.  Accurate Structure Prediction of CDR H3 Loops Enabled by a Novel Structure-Based C-Terminal Constraint.

Authors:  Brian D Weitzner; Jeffrey J Gray
Journal:  J Immunol       Date:  2016-11-21       Impact factor: 5.422

Review 7.  Integrating high-throughput screening and sequencing for monoclonal antibody discovery and engineering.

Authors:  Cristina Parola; Daniel Neumeier; Sai T Reddy
Journal:  Immunology       Date:  2017-10-30       Impact factor: 7.397

Review 8.  How repertoire data are changing antibody science.

Authors:  Claire Marks; Charlotte M Deane
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

Review 9.  Recent progress in the analysis of αβT cell and B cell receptor repertoires.

Authors:  Mark M Davis; Scott D Boyd
Journal:  Curr Opin Immunol       Date:  2019-07-18       Impact factor: 7.486

10.  Single-cell repertoire tracing identifies rituximab-resistant B cells during myasthenia gravis relapses.

Authors:  Ruoyi Jiang; Miriam L Fichtner; Kenneth B Hoehn; Minh C Pham; Panos Stathopoulos; Richard J Nowak; Steven H Kleinstein; Kevin C O'Connor
Journal:  JCI Insight       Date:  2020-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.